The World Health Organisation (WHO) has warned that counterfeit diabetes medications have been in circulation since 2022, an issue that affects all parts of the world.
In a statement, the health authorities cited studies from Britain, the United States, and Brazil since October 2023.
The drug is Ozempic, a medication containing the active component semaglutide that is also licenced in the EU for the treatment of type II diabetes.
The counterfeit drug appears to be similar to the original.
Because the medication inhibits hunger, it is increasingly being used for weight reduction purposes.
However, counterfeit medications may have insufficient active components, resulting in uncontrolled blood sugar in diabetics, according to the WHO.
It further said that they might include additional active chemicals that pose health hazards.
According to NAN, the WHO has urged doctors, chemists, regulatory agencies, and the general people to remain watchful.
According to the WHO, people should only acquire drugs with a prescription from pharmacies, not online.
Users should confirm that the dose scale on insulin pens is properly displayed, that the label seems right, and that the package contains no typographical errors.
Also Read:
Yahaya Bello hiding in Kogi Government House – PDP chieftain, Usman Okai
Lagos impounds 40 vehicles over illegal garages, obstruction
One shot dead in Nairobi as mass protest hits Kenya
cc: Daily Post Ng
